Advertisement

Index by author

May 01, 2015; Volume 353,Issue 2

  1. Bonin, Paul D.

    1. PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti–Glomerular Basement Membrane Glomerulonephritis
      Wei Zheng, Roscoe Warner, Roger Ruggeri, Chunyan Su, Christian Cortes, Athanasia Skoura, Jessica Ward, Kay Ahn, Amit Kalgutkar, Dexue Sun, Tristan S. Maurer, Paul D. Bonin, Carlin Okerberg, Walter Bobrowski, Thomas Kawabe, Yanwei Zhang, Timothy Coskran, Sammy Bell, Bhupesh Kapoor, Kent Johnson and Leonard Buckbinder
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 288-298; DOI: https://doi.org/10.1124/jpet.114.221788

  2. Brouwer, Kim L. R.

    1. Species Differences in Hepatobiliary Disposition of Taurocholic Acid in Human and Rat Sandwich-Cultured Hepatocytes: Implications for Drug-Induced Liver Injury
      Kyunghee Yang, Nathan D. Pfeifer, Kathleen Köck and Kim L. R. Brouwer
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 415-423; DOI: https://doi.org/10.1124/jpet.114.221564

  3. Buckbinder, Leonard

    1. PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti–Glomerular Basement Membrane Glomerulonephritis
      Wei Zheng, Roscoe Warner, Roger Ruggeri, Chunyan Su, Christian Cortes, Athanasia Skoura, Jessica Ward, Kay Ahn, Amit Kalgutkar, Dexue Sun, Tristan S. Maurer, Paul D. Bonin, Carlin Okerberg, Walter Bobrowski, Thomas Kawabe, Yanwei Zhang, Timothy Coskran, Sammy Bell, Bhupesh Kapoor, Kent Johnson and Leonard Buckbinder
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 288-298; DOI: https://doi.org/10.1124/jpet.114.221788

  4. Calani, Luca

    1. The Ellagic Acid Derivative 4,4′-Di-O-Methylellagic Acid Efficiently Inhibits Colon Cancer Cell Growth through a Mechanism Involving WNT16
      Ana Ramírez de Molina, Teodoro Vargas, Susana Molina, Jenifer Sánchez, Jorge Martínez-Romero, Margarita González-Vallinas, Roberto Martín-Hernández, Ruth Sánchez-Martínez, Marta Gómez de Cedrón, Alberto Dávalos, Luca Calani, Daniele Del Rio, Antonio González-Sarrías, Juan Carlos Espín, Francisco A. Tomás-Barberán and Guillermo Reglero
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 433-444; DOI: https://doi.org/10.1124/jpet.114.221796

  5. Castrop, Hayo

    1. In Vivo Visualization of the Antialbuminuric Effects of the Angiotensin-Converting Enzyme Inhibitor Enalapril
      Ina Maria Schießl, Veronika Kattler and Hayo Castrop
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 299-306; DOI: https://doi.org/10.1124/jpet.114.222125

  6. Chappell, Michael

    1. A Novel In Vivo Receptor Occupancy Methodology for the Glucocorticoid Receptor: Toward An Improved Understanding of Lung Pharmacokinetic/Pharmacodynamic Relationships
      Elin Boger, Pär Ewing, Ulf G. Eriksson, Britt-Marie Fihn, Michael Chappell, Neil Evans and Markus Fridén
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 279-287; DOI: https://doi.org/10.1124/jpet.114.221226

  7. Christopoulos, Arthur

    1. Endogenous Allosteric Modulators of G Protein–Coupled Receptors
      Emma T. van der Westhuizen, Celine Valant, Patrick M. Sexton and Arthur Christopoulos
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 246-260; DOI: https://doi.org/10.1124/jpet.114.221606

  8. Cortes, Christian

    1. PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti–Glomerular Basement Membrane Glomerulonephritis
      Wei Zheng, Roscoe Warner, Roger Ruggeri, Chunyan Su, Christian Cortes, Athanasia Skoura, Jessica Ward, Kay Ahn, Amit Kalgutkar, Dexue Sun, Tristan S. Maurer, Paul D. Bonin, Carlin Okerberg, Walter Bobrowski, Thomas Kawabe, Yanwei Zhang, Timothy Coskran, Sammy Bell, Bhupesh Kapoor, Kent Johnson and Leonard Buckbinder
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 288-298; DOI: https://doi.org/10.1124/jpet.114.221788

  9. Coskran, Timothy

    1. PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti–Glomerular Basement Membrane Glomerulonephritis
      Wei Zheng, Roscoe Warner, Roger Ruggeri, Chunyan Su, Christian Cortes, Athanasia Skoura, Jessica Ward, Kay Ahn, Amit Kalgutkar, Dexue Sun, Tristan S. Maurer, Paul D. Bonin, Carlin Okerberg, Walter Bobrowski, Thomas Kawabe, Yanwei Zhang, Timothy Coskran, Sammy Bell, Bhupesh Kapoor, Kent Johnson and Leonard Buckbinder
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 288-298; DOI: https://doi.org/10.1124/jpet.114.221788

  10. Cravatt, Benjamin F.

    1. Simultaneous Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Shares Discriminative Stimulus Effects with Δ9-Tetrahydrocannabinol in Mice
      Lenka Hruba, Alexandre Seillier, Armia Zaki, Benjamin F. Cravatt, Aron H. Lichtman, Andrea Giuffrida and Lance R. McMahon
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 261-268; DOI: https://doi.org/10.1124/jpet.115.222836
    2. Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice
      Bogna Ignatowska-Jankowska, Jenny L. Wilkerson, Mohammed Mustafa, Rehab Abdullah, Micah Niphakis, Jenny L. Wiley, Benjamin F. Cravatt and Aron H. Lichtman
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 424-432; DOI: https://doi.org/10.1124/jpet.114.222315
« Previous (Pages : 1 2 3 4 5 6 7 ... 15) Next »
Back to top

In this issue

Advertisement